Latest Mergers And Acquisitions News

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

James Hardie Industries plc reported a slight dip in FY25 sales and profits but met guidance, while announcing a transformative acquisition of The AZEK Company Inc to accelerate growth and synergies.

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

360 Capital Mortgage REIT has secured a new $9.2 million senior loan and extended a $17.6 million facility, enhancing its portfolio diversification and maintaining its FY25 distribution guidance.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Metro Mining’s latest update reveals a decline in Ore Reserves and Resources at Bauxite Hills Mine due to 2024 mining activity, with no new exploration additions. The company plans a significant capital expansion to boost production capacity.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Zoono Group has inked a five-year exclusive contract with Sharpak and OSY to apply its antimicrobial technology on UK soft fruit packaging, aiming to reduce food waste and boost shelf-life.

Bryah Resources has requested an immediate suspension of its shares on the ASX as it prepares to announce a significant acquisition. The suspension follows a recent trading halt and is expected to last until the announcement or the resumption of trading on May 21.